Endurance RP Limited
Regent Pacific Group Limited, an investment holding company, focuses on healthcare and life sciences sectors in Europe, the United States, and the Asia Pacific. The company operates through Biopharma and Corporate Investment segments. It is involved in the research, development, manufacturing, marketing, and sale of pharmaceutical products for the treatment and management of urological disorders;… Read more
Endurance RP Limited (RPGLF) - Total Liabilities
Latest total liabilities as of June 2025: $4.90 Million USD
Based on the latest financial reports, Endurance RP Limited (RPGLF) has total liabilities worth $4.90 Million USD as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Endurance RP Limited - Total Liabilities Trend (2001–2024)
This chart illustrates how Endurance RP Limited's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Endurance RP Limited Competitors by Total Liabilities
The table below lists competitors of Endurance RP Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
IDEMITSU KOSAN
BE:I7B
|
Germany | €2.78 Trillion |
|
NSK LTD
MU:NSK
|
Germany | €620.12 Billion |
|
BENETEAU (3GD.SG)
STU:3GD
|
Germany | €1.13 Billion |
|
TREDEGAR
BE:T70
|
Germany | €284.09 Million |
|
YOC - Dusseldorf Stock Exchang
DU:YOC
|
Germany | €10.91 Million |
|
Jse Ltd
BE:JF6
|
Germany | €55.40 Billion |
|
YD Bio Ltd
NASDAQ:YDES
|
USA | $19.00 Million |
Liability Composition Analysis (2001–2024)
This chart breaks down Endurance RP Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.15 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.18 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 6.68 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Endurance RP Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Endurance RP Limited (2001–2024)
The table below shows the annual total liabilities of Endurance RP Limited from 2001 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $6.51 Million | +49.75% |
| 2023-12-31 | $4.35 Million | -81.68% |
| 2022-12-31 | $23.72 Million | +1.11% |
| 2021-12-31 | $23.46 Million | -21.81% |
| 2020-12-31 | $30.00 Million | +26.19% |
| 2019-12-31 | $23.78 Million | +30.68% |
| 2018-12-31 | $18.20 Million | -9.28% |
| 2017-12-31 | $20.06 Million | -20.39% |
| 2016-12-31 | $25.19 Million | +564.70% |
| 2015-12-31 | $3.79 Million | +5.16% |
| 2014-12-31 | $3.60 Million | -3.69% |
| 2013-12-31 | $3.74 Million | -64.60% |
| 2012-12-31 | $10.57 Million | -54.31% |
| 2011-12-31 | $23.14 Million | -19.38% |
| 2010-12-31 | $28.70 Million | +336.95% |
| 2009-12-31 | $6.57 Million | -19.45% |
| 2008-12-31 | $8.15 Million | -63.47% |
| 2006-12-31 | $22.32 Million | +0.13% |
| 2005-12-31 | $22.30 Million | +5544.30% |
| 2004-12-31 | $395.00K | -64.03% |
| 2003-12-31 | $1.10 Million | -58.88% |
| 2002-12-31 | $2.67 Million | -67.83% |
| 2001-12-31 | $8.30 Million | -- |